Grufity logoGrufity logo
Stocks
Funds
Screener
Sectors
Watchlists
NAUT

NAUT - Nautilus Biotechnology, Inc. Stock Price, Fair Value and News

$2.07-0.16 (-7.17%)
Market Closed

Price Targets

NAUT Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

NAUT Price Action

Last 7 days

-5.1%

Last 30 days

6.7%

Last 90 days

46.8%

Trailing 12 Months

15%

NAUT RSI Chart

NAUT Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

NAUT Valuation

Market Cap

261.5M

Price/Earnings (Trailing)

-4.16

Price/Free Cashflow

-4.85

NAUT Price/Earnings (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

NAUT Fundamentals

NAUT Earnings

Earnings (TTM)

-62.8M

Earnings Growth (Yr)

17.46%

Earnings Growth (Qtr)

9.71%

NAUT Profitability

Return on Equity

-37.14%

Return on Assets

-31.26%

Free Cashflow Yield

-20.62%

NAUT Investor Care

Shares Dilution (1Y)

0.59%

Diluted EPS (TTM)

-0.5

About Nautilus Biotechnology, Inc.

NAUT
Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. It develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. The company was incorporated in 2016 and is headquartered in Seattle, Washington.
 CEO
 WEBSITEnautilus.bio
 SECTORHealthcare
 INDUSTRYBiotechnology
 EMPLOYEES153

Nautilus Biotechnology, Inc. Frequently Asked Questions

NAUT is the stock ticker symbol of Nautilus Biotechnology, Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

As of Wed Jan 28 2026, market cap of Nautilus Biotechnology, Inc. is 261.45 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

You can check NAUT's fair value in chart for subscribers.

The fair value guage provides a quick view whether NAUT is over valued or under valued. Whether Nautilus Biotechnology, Inc. is cheap or expensive depends on the assumptions which impact Nautilus Biotechnology, Inc.'s fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for NAUT.